Pardes Biosciences Funding & Investors
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus. The Carlsbad, California-based company was established by Uri Lopatin in 2020.
pardesbio.comTotal Amount Raised: $126,614,992
Pardes Biosciences Funding Rounds
Post Ipo Equity
$75,000,000
Post Ipo Equity Investors
Foresite CapitalMonashee Investment ManagementRa Capital ManagementEcoR1 CapitalGilead SciencesGMF CapitalFrazier ManagementT. Rowe PriceUndisclosed
$51,614,997
Undisclosed Investors
Y Combinator
Funding info provided by Diffbot.